< b > < i > NOS3 < /i > < /b > 895G & gt;T and < b > < i > CBR3 < /i > < /b > 730G & gt;A Are Associated with Recurrence Risk in Non-Muscle-Invasive Bladder Cancer with Intravesical Instillations of THP

Conclusions: Our results suggest thatNOS3 895G#x3e;T andCBR3 730G#x3e;A are genetic markers that can be used to predict tumor recurrence in NMIBC patients receiving intravesical instillations of THP. The effects of those 2 SNPs are independent of the EORTC scores. Further studies with larger sample sizes and longer follow-ups are needed to confirm our results.Chemotherapy 2018;63:191 –197
Source: Chemotherapy - Category: Cancer & Oncology Source Type: research